The next revolution in stroke care

Expert Review of Neurotherapeutics

Volumn 14, Issue 11, 2014, Pages 1307-1314

  Teasell, Robert ^a,b,c   Rice, Danielle ^a   Richardson, Marina ^a   Campbell, Nerissa ^a   Madady, Mona ^a   Hussein, Norhayati ^d   Murie Fernandez, Manuel ^e   Page, Stephen ^f  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

^b PARKWOOD HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d Cheras Rehabilitation Hospital   (Malaysia)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

acute care; prevention; rehabilitation; stroke

Indexed keywords

FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ALCOHOL CONSUMPTION; BLOOD CLOT LYSIS; BODY MASS; CEREBROVASCULAR ACCIDENT; COGNITIVE REHABILITATION; COMMUNITY REINTEGRATION; CONSTRAINT INDUCED THERAPY; DEPRESSION; DRUG COST; EMERGENCY CARE; HUMAN; LENGTH OF STAY; LIFESTYLE MODIFICATION; NEUROPROTECTION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; QUALITY OF LIFE; REVIEW; RISK FACTOR; STROKE PATIENT; STROKE UNIT; TREATMENT DURATION; WEIGHT REDUCTION; BRAIN ISCHEMIA; STROKE;

BRAIN ISCHEMIA; HUMANS; QUALITY OF LIFE; STROKE;

EID: 84911932298     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2014.968130     Document Type: Review

References (102)

1. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet Global Health 2013;1(5):e259-81
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2095-128
3. Murray CJ, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859): 2197-223
4. Murray CJ, Vos T, Lozano R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383(9913):245-54
5. Hakim AM, Silver F, Hodgson C. Is Canada falling behind international standards for stroke care CMAJ 1998; 159(6):671-3
6. Canadian Community Health Survey. Statistics Canada Catalogue Health Profile. Statistics Canada, Government of Canada, 2009
7. Tracking Heart Disease and Stroke in Canada. Stroke Highlights. Public Health Agency of Canada, 2011. Available from: www.publichealth,g.c.canada
8. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990. Stroke 2002;33(4):1034-40
9. Hackett ML, Duncan JR, Anderson CS, et al. Health-related quality of life among long-term survivors of stroke : results from the Auckland Stroke Study, 1991-1992. Stroke 2000;31(2):440-7
10. Sit JW, Wong TK, Clinton M, et al. Stroke care in the home: the impact of social support on the general health of family caregivers. J Clin Nurs 2004;13(7):816-24
11. Godwin KM, Ostwald SK, Cron SG, Wasserman J. Long-term health-related quality of life of stroke survivors and their spousal caregivers. J Neurosci Nurs 2013; 45(3):147-54
12. Morimoto T, Schreiner AS, Asano H. Caregiver burden and health-related quality of life among Japanese stroke caregivers. Age Ageing 2003;32(2):218-23
13. Simon C, Kumar S, Kendrick T. Cohort study of informal carers of first-time stroke survivors: profile of health and social changes in the first year of caregiving. Soc Sci Med 2009;69(3):404-10
14. White CL, Poissant L, Coté-LeBlanc G, et al. Long-term caregiving after stroke: the impact on caregivers' quality of life. J Neurosci Nurs 2006;38(5):354-60
15. Berg A, Palomäki H, Lönnqvist J, et al. Depression among caregivers of stroke survivors. Stroke 2005;36(3):639-43
16. Visser-Meily A, Post M, van de Port I, et al. Psychosocial functioning of spouses in the chronic phase after stroke: improvement or deterioration between 1 and 3 years after stroke Patient Educ Couns 2008;73(1): 153-8
17. Rigby H, Gubitz G, Phillips S. A systematic review of caregiver burden following stroke. Int J Stroke 2009;4(4):285-92
18. Teasell R, Mehta S, Pereira S, et al. Time to rethink long-term rehabilitation management of stroke patients. Top Stroke Rehabil 2012;19(6):457-62
19. Lindsay MP, Gubitz G, Bayley M, Phillips S; Canadian Stroke Strategy Best Practices and Standards Writing Group. Canadian best practice recommendations for stroke care. Canadian Stroke Network, Canada; 2012
20. Bousser MG. Stroke prevention: an update. Front Med 2012;6(1):22-34
21. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. Bmj 2003;326(7404):1419
22. Sacco RL, Benjamin EJ, Broderick JP, et al. Risk factors. Stroke 1997;28(7):1507-17
23. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009; 8(5):453-63
24. Sarti C, Kaarisalo M, Tuomilehto J. The relationship between cholesterol and stroke. Implications for antihyperlipidaemic therapy in older patients. Drugs and Aging 2000; 17(1):33-51
25. Tanizaki Y, Kiyohara Y, Kato I, et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000;31(11): 2616-22
26. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493): 1267-78
27. Amarenco P, Goldstein LB, Callahan A III, et al. Baseline blood pressure, low-and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis 2009;204(2):515-20
28. MacDougall NJ, S, Amarasinghe KW, Muir Secondary prevention of stroke. Expert Rev Cardiovasc Ther 2009;7(9):1103-15
29. Ockene JK, Schneider KL, Lemon SC, Ockene IS. Can we improve adherence to preventive therapies for cardiovascular health Circulation 2011;124(11):1276-82
30. ADVANCE Collaborative Group. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358(24):2560-72
31. Gerstein H.C, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358(24):2545-59
32. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360(2):129-39
33. Hu G, Tuomilehto J, Silventoinen K, et al. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007; 167(13):1420-7
34. Troiano RP, Berrigan D, Dodd KW, et al. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 2008;40(1):181-8
35. Rand D, Eng JJ, Tang PF, et al. How active are people with stroke: use of accelerometers to assess physical activity. Stroke 2009;40(1):163-8
36. Field M.J, Gebruers N, Sundaram TS, et al. Physical Activity after Stroke: A Systematic Review and Meta-Analysis. ISRN Stroke 2013;13:2013
37. Pang MY, Charlesworth SA, Lau RW, et al. Using aerobic exercise to improve health outcomes and quality of life in stroke: evidence-based exercise prescription recommendations. Cerebrovasc Dis 2013; 35(1):7-22
38. Tudor-Locke C, Craig CL, Brown WJ, et al. How many steps/day are enough For adults. Int J Behav Nutr Phys Act 2011;8:79
39. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology 1998;50(4):883-90
40. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. The Lancet 2012;379(9834):2364-72
41. Schellinger PD, Kohrmann M. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly. Stroke 2014;45:912-3
42. Wechsler LR. The 4.5-hour time window for intravenous thrombolysis with intravenous tissue-type plasminogen activator is not firmly established. Stroke 2014;45:914-5
43. Penaloza-Ramos MC, Sheppard JP, Jowett S, et al. Cost-effectiveness of optimizing acute stroke care services for thrombolysis. Stroke 2014;45(2):553-62
44. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333(24):1581-7
45. Minnerup J, Sutherland BA, Buchan AM, et al. Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci 2012;13(9):11753-72
46. Xu XL, Yi F, Pan HZ, et al. Progress and prospects in stem cell therapy. Acta Pharmacol Sin 2013;34(6):741-6
47. Tymianski M. Novel approaches to neuroprotection trials in acute ischemic stroke. Stroke 2013;44(10):2942-50
48. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009;40(3 Suppl): S111-14
49. Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009;8(4):355-69
50. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. Jama 2006;296(24):2939-46
51. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363(9425):1925-33
52. Lindsay MP, Gubitz G, Bayley M, et al. Canadian best practice recommendations for stroke care (update). Canadian stroke strategy best practices and standards writing Group; Ottawa(ON), Canada: 2010
53. Liu X, Ye R, Yan T, et al. Cell based therapies for ischemic stroke: From basic science to bedside. Prog Neurobiol 2014;115:92-115
54. Rosado-de-Castro PH, Pimentel-Coelho PM, da Fonseca LM, et al. The rise of cell therapy trials for stroke: review of published and registered studies. Stem Cells Dev 2013; 22(15):2095-111
55. Fargen KM, J, Mocco BL, Hoh Can we rebuild the human brain The exciting promise and early evidence that stem cells may provide a real clinical cure for stroke in humans. World Neurosurg 2013;80(5):e69-72
56. Lees JS, Sena ES, Egan KJ, et al. Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke 2012;7(7):582-8
57. Teasell R, Richardson M, Allen L, Hussein N. Evidence-based review of stroke rehabilitation. 16th edition. 2014. Available from: www.ebrsr.com
58. How do stroke units improve patient outcomes A collaborative systematic review of the randomized trials. Stroke Unit Trialists Collaboration. Stroke 1997;28(11):2139-44
59. Foley N, Salter K, Teasell R. Specialized stroke services: a meta-analysis comparing three models of care. Cerebrovascular Diseases 2007;23(2-3):194-202
60. Rønning OM, Guldvog B. Outcome of subacute stroke rehabilitation: a randomized controlled trial. Stroke 1998;29(4):779-84
61. Leys D, et al. Facilities available in European hospitals treating stroke patients. Stroke 2007;38(11):2985-91
62. Gagnon D, Nadeau S, Tam V. Ideal timing to transfer from an acute care hospital to an interdisciplinary inpatient rehabilitation program following a stroke: An exploratory study. BMC Health Serv Res 2006. 6:151
63. Biernaskie J, Chernenko G, Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci 2004;24(5):1245-54
64. Bai Y, Hu Y, Wu Y, et al. A prospective, randomized, single-blinded trial on the effect of early rehabilitation on daily activities and motor function of patients with hemorrhagic stroke. J Clin Neurosci 2012;19(10):1376-9
65. Paolucci S, Antonucci G, Grasso MG, et al. Early versus delayed inpatient stroke rehabilitation: a matched comparison conducted in Italy. Arch Phys Med Rehabil 2000;81(6):695-700
66. Salter K, Jutai J, Hartley M, et al. Impact of early vs delayed admission to rehabilitation on functional outcomes in persons with stroke. J Rehabil Med 2006; 38(2):113-7
67. Bernhardt J, Dewey H, Thrift A, et al. A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility. Stroke 2008;39(2):390-6
68. Cumming TB, Thrift AG, Collier JM, et al. Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke 2011;42(1):153-8
69. Foley N, McClure JA, Meyer M, et al. Inpatient rehabilitation following stroke: amount of therapy received and associations with functional recovery. Disabil Rehabil 2012;34(25):2132-8
70. Scrivener K, Sherrington C, Schurr K. Exercise dose and mobility outcome in a comprehensive stroke unit: description and prediction from a prospective cohort study. J Rehabil Med 2012;44(10):824-9
71. English C, Hillier SL. Circuit class therapy for improving mobility after stroke. Cochrane Database Syst Rev 2010(7): CD007513
72. French B, Thomas LH, Leathley MJ, et al. Repetitive task training for improving functional ability after stroke. Cochrane Database Syst Rev 2007(4):CD006073
73. van de Port IG, Wood-Dauphinee S, Lindeman E, Kwakkel G. Effects of exercise training programs on walking competency after stroke: a systematic review. Am J Phys Med Rehabil 2007;86(11):935-51
74. Dromerick AW, Lang CE, Birkenmeier RL, et al. Very early constraint-induced movement during stroke rehabilitation (VECTORS): a single-center RCT. Neurology 2009;73(3):195-201
75. Duncan PW, Sullivan KJ, Behrman AL, et al. Body-weight-Supported treadmill rehabilitation after stroke. N Engl J Med 2011;364(21):2026-36
76. Lo AC, Guarino PD, Richards LG, et al. Robot-assisted therapy for long-term upperlimb impairment after stroke. N Engl J Med 2010;362(19):1772-83
77. Page SJ, Hill V, White S. Portable upper extremity robotics is as efficacious as upper extremity rehabilitative therapy: a randomized controlled pilot trial. Clin Rehabil 2013;27(6):494-503
78. Cumming TB, Marshall RS, Lazar RM. Stroke, cognitive deficits, and rehabilitation: still an incomplete picture. Int J Stroke 2013;8(1):38-45
79. Bruno-Petrina A. Motor recovery in stroke. Medscape 2014. Available from: http://emedicine.medscape.com/article/324386
80. Srikanth VK, Thrift AG, Saling MM, et al. Increased risk of cognitive impairment 3 months after mild to moderate first-ever stroke: a community-based prospective study of nonaphasic english-speaking survivors. Stroke 2003;34(5):1136-43
81. Ballard C, Rowan E, Stephens S, et al. Prospective follow-up study between 3 and 15 months after stroke: Improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke 2003;34(10):2440-4
82. Hurford R, Charidimou A, Fox Z, et al. Domain-specific trends in cognitive impairment after acute ischaemic stroke. J Neurol 2013;260(1):237-41
83. Brady MC, Kelly H, Godwin J, Enderby P. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2012;5:Cd000425
84. Diamond PT, Holroyd S, Macciocchi SN, Felsenthal G. Prevalence of depression and outcome on the geriatric rehabilitation unit. Am J Phys Med Rehabil 1995;74(3):214-17
85. Van De Weg FB, Kuik DJ, Lankhorst GJ. Post-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil 1999; 13(3):268-72
86. Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001;71(2):258-61
87. Mead GE, Hsieh CF, Lee R, et al. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke 2013;44(3):844-50
88. Teasell R, et al. Stroke: more than a 'brain attack'. Int J Stroke 2014;9(2):188-90
89. Korner-Bitensky N. When does stroke rehabilitation end Int J Stroke 2013;8(1): 8-10
90. Page SJ, Sisto S, Levine P, McGrath RE. Efficacy of modified constraint-induced movement therapy in chronic stroke: a single-blinded randomized controlled trial. Arch Phys Med Rehabil 2004;85(1):14-18
91. Lee MJ, Kilbreath SL, Singh MF. Comparison of effect of aerobic cycle training and progressive resistance training on walking ability after stroke: a randomized sham exercise-controlled study. J Am Geriatr Soc 2008;56(6):976-85
92. Chu KS, Eng JJ, Dawson AS, et al. Water-based exercise for cardiovascular fitness in people with chronic stroke: a randomized controlled trial. Arch Phys Med Rehabil 2004;85(6):870-4
93. Pang MY, Eng JJ, Dawson AS, et al. A community-based fitness and mobility exercise program for older adults with chronic stroke: a randomized, controlled trial. J Am Geriatr Soc 2005;53(10):1667-74
94. Wolf SL, Thompson PA, Winstein CJ, et al. The EXCITE stroke trial: comparing early and delayed constraint-induced movement therapy. Stroke 2010;41(10):2309-15
95. Wu CY, Chuang LL, Lin KC, et al. Randomized trial of distributed constraint-induced therapy versus bilateral arm training for the rehabilitation of upper-limb motor control and function after stroke. Neurorehabil Neural Repair 2011; 25(2):130-9
96. Meinzer M, Streiftau S, Rockstroh B. Intensive language training in the rehabilitation of chronic aphasia: efficient training by laypersons. J Int Neuropsychol Soc 2007;13(5):846-53
97. Nudo RJ, Wise BM, SiFuentes F, Milliken GW. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996;272(5269):1791-4
98. Dobkin BH, Dorsch A. New evidence for therapies in stroke rehabilitation. Curr Atheroscler Rep 2013;15(6):331
99. Canadian Stroke Network. The quality of stroke care in Canada. 2011
100. Gilligan AK, Thrift AG, Sturm JW, et al. Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit Cerebrovascular Diseases 2005;20(4):239-44
101. Donnan GA, Howells DW, Markus R, et al. Can the time window for administration of thrombolytics in stroke be increased CNS Drugs 2003;17(14):995-1011
102. Saposnik G, Johnston SC, Raptis S, et al. Stroke journal: what is being published to advance the field Stroke 2013;44(9):2644-9